| Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report P Malfertheiner, F Megraud, C O’Morain, F Bazzoli, E El-Omar, D Graham, ... Gut 56 (6), 772-781, 2007 | 5448* | 2007 |
| Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data M Maas, PJ Nelemans, V Valentini, P Das, C Rödel, LJ Kuo, FA Calvo, ... The lancet oncology 11 (9), 835-844, 2010 | 1987 | 2010 |
| ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making HJ Schmoll, E Van Cutsem, A Stein, V Valentini, B Glimelius, ... Annals of oncology 23 (10), 2479-2516, 2012 | 1848 | 2012 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1739* | 2021 |
| Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up R Glynne-Jones, L Wyrwicz, E Tiret, G Brown, C Rödel, A Cervantes, ... Annals of Oncology 28, iv22-iv40, 2017 | 1732 | 2017 |
| Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study Quasar Collaborative Group The Lancet 370 (9604), 2020-2029, 2007 | 1655 | 2007 |
| Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label … RD James, R Glynne-Jones, HM Meadows, D Cunningham, AS Myint, ... The lancet oncology 14 (6), 516-524, 2013 | 715 | 2013 |
| Adjuvant chemotherapy after preoperative (chemo) radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data AJ Breugom, M Swets, JF Bosset, L Collette, A Sainato, L Cionini, ... The lancet oncology 16 (2), 200-207, 2015 | 601 | 2015 |
| Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients C Capirci, V Valentini, L Cionini, A De Paoli, C Rodel, R Glynne-Jones, ... International Journal of Radiation Oncology* Biology* Physics 72 (1), 99-107, 2008 | 550 | 2008 |
| Anal cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up R Glynne-Jones, PJ Nilsson, C Aschele, V Goh, D Peiffert, A Cervantes, ... Radiotherapy and Oncology 111 (3), 330-339, 2014 | 546 | 2014 |
| Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline JE Van Hooft, EE Van Halsema, G Vanbiervliet, RGH Beets-Tan, ... Endoscopy, 990-1053, 2014 | 538 | 2014 |
| Multidisciplinary team working in cancer: what is the evidence? C Taylor, AJ Munro, R Glynne-Jones, C Griffith, P Trevatt, M Richards, ... Bmj 340, 2010 | 497 | 2010 |
| Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I) J Northover, R Glynne-Jones, D Sebag-Montefiore, R James, H Meadows, ... British journal of cancer 102 (7), 1123-1128, 2010 | 432 | 2010 |
| Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013 D Papamichael, RA Audisio, B Glimelius, A de Gramont, R Glynne-Jones, ... Annals of oncology 26 (3), 463-476, 2015 | 428 | 2015 |
| Corrections to “Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up” R Glynne-Jones, L Wyrwicz, E Tiret, G Brown, C Rödel, A Cervantes, ... Annals of Oncology 29, iv263, 2018 | 352 | 2018 |
| Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized … AD Roth, N Fazio, R Stupp, S Falk, J Bernhard, P Saletti, D Köberle, ... Journal of Clinical Oncology 25 (22), 3217-3223, 2007 | 343 | 2007 |
| Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus … R Glynne-Jones, N Counsell, P Quirke, N Mortensen, A Maraveyas, ... Annals of oncology 25 (7), 1356-1362, 2014 | 317 | 2014 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 316 | 2021 |
| Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes Journal of British Surgery 100 (8), E1-E33, 2013 | 307 | 2013 |
| Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial. LC Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL ... Lancet Oncol. 2014 15 ((8):), 862-73, 2014 | 306 | 2014 |
